These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 2857154)
21. Antibody responses after vaccination and disease against leukocytosis promoting factor, filamentous hemagglutinin, lipopolysaccharide and a protein binding to complement-fixing antibodies induced during whooping cough. Winsnes R; Lønnes T; Møgster B; Berdal BP Dev Biol Stand; 1985; 61():353-65. PubMed ID: 2872124 [TBL] [Abstract][Full Text] [Related]
22. Synergistic effect of Bordetella pertussis lymphocytosis-promoting factor on protective activities of isolated Bordetella antigens in mice. Robinson A; Irons LI Infect Immun; 1983 May; 40(2):523-8. PubMed ID: 6301999 [TBL] [Abstract][Full Text] [Related]
23. Mice are protected against Bordetella pertussis infection by intra-nasal immunization with filamentous haemagglutinin. Cahill ES; O'Hagan DT; Illum L; Redhead K FEMS Microbiol Lett; 1993 Mar; 107(2-3):211-6. PubMed ID: 8472903 [TBL] [Abstract][Full Text] [Related]
24. Preparation of filamentous hemagglutinin from Bordetella pertussis and assay for serum antibodies to filamentous hemagglutinin and pertussis toxin for clinical and public health laboratories. Wong KH; Skelton SK J Clin Microbiol; 1989 Dec; 27(12):2805-10. PubMed ID: 2556434 [TBL] [Abstract][Full Text] [Related]
25. Protective role of immunoglobulin G antibodies to filamentous hemagglutinin and pertactin of Bordetella pertussis in Bordetella parapertussis infection. He Q; Edelman K; Arvilommi H; Mertsola J Eur J Clin Microbiol Infect Dis; 1996 Oct; 15(10):793-8. PubMed ID: 8950556 [TBL] [Abstract][Full Text] [Related]
26. Pertussis encephalopathy with a normal brain biopsy and elevated lymphocytosis-promoting factor antibodies. Davis LE; Burstyn DG; Manclark CR Pediatr Infect Dis; 1984; 3(5):448-51. PubMed ID: 6093068 [No Abstract] [Full Text] [Related]
27. Comparison of the protective effects of the pertussis acellular vaccine with the component vaccine, which have different amounts of fimbriae, against the experimental aerosol infection of mice with Bordetella pertussis. Morokuma K; Ginnaga A; Nishihara T; Tsunoda S; Furukawa M; Aihara K; Sakoh M Dev Biol Stand; 1991; 73():223-32. PubMed ID: 1685713 [TBL] [Abstract][Full Text] [Related]
28. Immunogenicity and protective efficacy of a recombinant filamentous haemagglutinin from Bordetella pertussis. Knight JB; Huang YY; Halperin SA; Anderson R; Morris A; Macmillan A; Jones T; Burt DS; Van Nest G; Lee SF Clin Exp Immunol; 2006 Jun; 144(3):543-51. PubMed ID: 16734625 [TBL] [Abstract][Full Text] [Related]
29. Adjuvanticity of native and detoxified adenylate cyclase toxin of Bordetella pertussis towards co-administered antigens. Macdonald-Fyall J; Xing D; Corbel M; Baillie S; Parton R; Coote J Vaccine; 2004 Oct; 22(31-32):4270-81. PubMed ID: 15474718 [TBL] [Abstract][Full Text] [Related]
30. Comparison of biological activities of Bordetella pertussis mutants lacking the ability to produce filamentous hemagglutinin with similar activities of other smooth strains. Watanabe M; Munoz JJ Microbiol Immunol; 1982; 26(10):965-9. PubMed ID: 6298581 [No Abstract] [Full Text] [Related]
31. [Detection of Bordetella pertussis infection by culture, real-time polymerase chain reaction and serologic tests among children with prolonged cough]. Gürsel D; Aslan A; Sönmez C; Koturoğlu G; Cöplü N; Kurugöl Z; Aydemir S Mikrobiyol Bul; 2012 Apr; 46(2):211-24. PubMed ID: 22639310 [TBL] [Abstract][Full Text] [Related]
32. Antigens in whooping cough vaccine and antibody levels induced by vaccination of children. Ashworth LA; Robinson A; Irons LI; Morgan CP; Isaacs D Lancet; 1983 Oct; 2(8355):878-81. PubMed ID: 6137697 [TBL] [Abstract][Full Text] [Related]
33. Role of pertussigen (pertussis toxin) on the mouse protective activity of vaccines made from Bordetella species. Munoz JJ; Peacock MG Microbiol Immunol; 1989; 33(4):341-55. PubMed ID: 2549344 [TBL] [Abstract][Full Text] [Related]
34. Modulation of Bordetella pertussis infection with monoclonal antibodies to pertussis toxin. Halperin SA; Issekutz TB; Kasina A J Infect Dis; 1991 Feb; 163(2):355-61. PubMed ID: 1703192 [TBL] [Abstract][Full Text] [Related]
35. Mouse-protecting and histamine-sensitizing activities of pertussigen and fimbrial hemagglutinin from Bordetella pertussis. Munoz JJ; Arai H; Cole RL Infect Immun; 1981 Apr; 32(1):243-50. PubMed ID: 6260681 [TBL] [Abstract][Full Text] [Related]
37. Immunoglobulin A antibodies to pertussis toxin and filamentous hemagglutinin in saliva from patients with pertussis. Zackrisson G; Lagergård T; Trollfors B; Krantz I J Clin Microbiol; 1990 Jul; 28(7):1502-5. PubMed ID: 2380376 [TBL] [Abstract][Full Text] [Related]
38. Separation and purification of the hemagglutinins from Bordetella pertussis. Sato Y; Cowell JL; Sato H; Burstyn DG; Manclark CR Infect Immun; 1983 Jul; 41(1):313-20. PubMed ID: 6305841 [TBL] [Abstract][Full Text] [Related]
39. Serum antibody response to B. pertussis Tn5 mutants, purified PT and FHA in two different mouse strains and passive protection in the murine intranasal infection model. Olander RM; Muotiala A; Karvonen M; Kuronen T; Runeberg-Nyman K Microb Pathog; 1990 Jan; 8(1):37-45. PubMed ID: 2159104 [TBL] [Abstract][Full Text] [Related]